S100A9 and neoplasm: There was a remarkable and significant increase of positive IRS regarding the tumor center compared to the invasion front for both HPV+ (p = 0.0093) and HPV− (p = 0.0013) PeCa for the Calprotectin subunit S100A9 but not for S100A8 (Figures 1E, F).